1-5 of 5
Shane Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Etentamig plus pomalidomide-dexamethasone combination therapy in relapsed or refractory multiple myeloma: A phase 1b dose-escalation and safety expansion study

Free
Peter Voorhees, Anita D'Souza, Hang Quach, Sabine Gaerditz, Estrella Carrillo-Cruz, Michał Mielnik, Tomasz Wrobel, Matthew Pianko, Dickran Kazandjian, M Hasib Sidiqi, Valerio De Stefano, Cesar Rodriguez Valdes, Shonali Midha, Ariel Grajales-Cruz, Hideki Goto, Satoshi Ito, Claudio Cerchione, Ziyi Jin, Shane Lee, Akshanth Polepally, Sneha Rathi, Ross La Motte-Mohs, Kristin D'Amico, Thomas Doerr, Chetasi Talati, Leanne Lash Fleming, Linda Ho, Katja Weisel, Marek Hus, Joaquin Martinez-Lopez
Journal: Blood
Blood (2025) 146 (Supplement 1): 247.
https://doi.org/10.1182/blood-2025-247
Published: 2025
Journal Articles

ABBV-383 Plus Daratumumab-Dexamethasone in Relapsed or Refractory Multiple Myeloma: A Phase 1b Dose-Escalation and Safety Expansion Study

Free
Cesar Rodriguez, Michal Mielnik, Dickran Kazandjian, Wojt Janowski, Michael S.Y. Low, Matthew Pianko, Junichiro Yuda, Carrie Van Der Weyden, Larry D Anderson, Jr., Rahul Banerjee, Laura Rosinol Dachs, Claudio Cerchione, Malin Hultcrantz, Anita D'Souza, Amandeep Godara, Ariel Grajales-Cruz, Ziyi Jin, Akshanth R Polepally, Aarif Ahsan, Shane Lee, Kristin D'Amico, Orlando Bueno, Chetasi Talati, Anders Erik Svensson, Leanne Fleming, Katja C. Weisel, Marek Hus, Peter M. Voorhees
Journal: Blood
Blood (2024) 144 (Supplement 1): 496.
https://doi.org/10.1182/blood-2024-205083
Published: 2024
Journal Articles

A Phase 1b Study of Step-up Dosing with ABBV-383, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Patients with Relapsed or Refractory Multiple Myeloma

Free
Hira Mian, Muhamed Baljevic, Hila Magen, Moshe E Gatt, Irit Avivi Mazza, Emma Searle, Eben I Lichtman, John T. McKay, Torben Plesner, Cesar Rodriguez, Neha Korde, Hana Safah, Iuliana Vaxman, Chetasi Talati, Anders Erik Svensson, Ziyi Jin, Shane Lee, Thomas Doerr, Rajvineeth Kumar Pothacamury, Tanya S Rosenberg, Akshanth R Polepally, Jeremy A. Ross, Shaji Kumar
Journal: Blood
Blood (2024) 144 (Supplement 1): 1985.
https://doi.org/10.1182/blood-2024-206912
Published: 2024
Journal Articles

Updated Safety and Efficacy Results of Abbv-383, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in a First-in-Human Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma

Free
Ravi Vij, Shaji Kunnathu Kumar, Anita D'Souza, John T Mckay, Peter M. Voorhees, Alfred Chung, Sascha Alexander Tuchman, Neha Korde, Katja Weisel, Raphael Teipel, Orlando Bueno, Zhongling Feng, Tanya S Rosenberg, Rajvineeth Kumar Pothacamury, Akshanth R Polepally, Shane Lee, Ziyi Jin, Jeremy A Ross, Aarif Ahsan, Chetasi Talati, Cesar Rodriguez
Journal: Blood
Blood (2023) 142 (Supplement 1): 3378.
https://doi.org/10.1182/blood-2023-182388
Published: 2023
Journal Articles

A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma

Free
Peter M. Voorhees, Anita D'Souza, Katja Weisel, David Duane Hurd, Raphael Teipel, Alfred Chung, Cesar Rodriguez, Sascha A. Tuchman, Neha Korde, Hana Safah, Orlando F. Bueno, Neil Pumford, Tanya S Rosenberg, Rajvineeth Kumar Pothacamury, Jeremy A. Ross, Akshanth R. Polepally, Shane Lee, Ziyi Jin, Chetasi Talati, Ravi Vij, Shaji K Kumar
Journal: Blood
Blood (2022) 140 (Supplement 1): 4401–4404.
https://doi.org/10.1182/blood-2022-167008
Published: 2022